Similarly, analysis of the expression of nectin-4, a ligand that is overexpressed in many tumor types (including breast cancer) and that exclusively interacts with TIGIT and not with CD226 (46), might give a more comprehensive picture of this axis. This evidence concerns the gene NECTIN4 and breast carcinoma.